EP
PODD icon

Evelyn Partners’s Insulet PODD Stock Holding History

Evelyn Partners’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.7K Buy
+425
New +$70.8K ﹤0.01% 348

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evelyn Partners's PODD Position: Q2 2026 in Review

Evelyn Partners opened a new position in Insulet (PODD) in Q2 2026: 425 shares worth $64.7K. The stake represents ﹤0.01% of the portfolio and ranks #348 among its holdings.

680 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Evelyn Partners held 425 shares of Insulet worth $64.7K as of Q2 2026.
  • Insulet was a new Evelyn Partners position in Q2 2026.
  • Insulet made up ﹤0.01% of Evelyn Partners's portfolio in Q2 2026, its #348 holding.
  • 680 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Evelyn Partners's 13F filing for Q2 2026, filed 7 Aug 2026.